Discovery Life Sciences
Discovery Life Sciences, headquartered in the United States, is a leading provider in the biospecimen and laboratory services industry. Founded in 2013, the company has rapidly established itself as a key player, offering a comprehensive range of services that include biospecimen procurement, biobanking, and advanced laboratory testing. With operational facilities across major regions in the US, Discovery Life Sciences is renowned for its commitment to quality and innovation. Their unique approach combines cutting-edge technology with a deep understanding of the life sciences sector, ensuring that clients receive unparalleled support in their research and development efforts. Notable achievements include a robust portfolio of core products and services that cater to the needs of pharmaceutical, biotechnology, and academic institutions. Discovery Life Sciences continues to solidify its market position through strategic partnerships and a dedication to advancing scientific discovery.
DitchCarbon Score
How does Discovery Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Discovery Life Sciences's score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Discovery Life Sciences's reported carbon emissions
Discovery Life Sciences, headquartered in the United States, is committed to addressing climate change through various initiatives, although specific carbon emissions data for the most recent year is currently unavailable. The company has made a commitment to near-term climate targets, as indicated by its status with the Science Based Targets initiative (SBTi). While Discovery Life Sciences has not set a net-zero target, it is actively engaged in reducing its carbon footprint within the pharmaceuticals, biotechnology, and life sciences sector. The company is classified as "Committed" to near-term targets, reflecting its dedication to sustainability and climate action. As of now, there are no specific reduction targets or achievements disclosed, but the commitment to near-term targets suggests a proactive approach to managing and mitigating carbon emissions in the future. Discovery Life Sciences is focused on aligning its operations with industry standards for climate responsibility, contributing to a more sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Discovery Life Sciences is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
